Regulus Therapeutics Inc - Company Profile
Powered by 
All the data and insights you need on Regulus Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Regulus Therapeutics Inc Strategy Report
- Understand Regulus Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Regulus Therapeutics Inc (Regulus) is a biopharmaceutical company that focuses on the discovery and development of microRNA-based therapeutics for orphan kidney diseases such as autosomal dominant polycystic kidney diseases. Its pipeline products include ADPKD is developed for the treatment of autosomal dominant polycystic kidney disease. It offers services such as clinical trials. The company is also evaluating therapies against infectious diseases and central nervous system disorders. It utilizes its proprietary microRNA development platform to discover and develop its therapies for cancer, fibrosis, metabolic and inflammatory disorders. Regulus Therapeutics is headquartered in San Diego, California, the US.
Headquarters
United States of America
Address
Suite 210, 3545 John Hopkins Court, San Diego, California, 92121
Website
www.regulusrx.com
Telephone
1 858 2026300
No of Employees
30
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
RGLS (NASD)
EPS
XYZ
Net Income (2022)
XYZ
-6.1%
(2022 vs 2021)
Market Cap*
$145.3M
Net Profit Margin (2019)
XYZ
0.0%
(2022 vs 2021)
* As of and is in US$
Regulus Therapeutics Inc premium industry data and analytics
Products and Services
| Products | Services |
|---|---|
| Pipeline | Clinical Trials |
| ADPKD- Autosomal Dominant Polycystic Kidney Disease |
Competitor Comparison
| Key Parameters | Regulus Therapeutics Inc | Ionis Pharmaceuticals Inc | Arrowhead Pharmaceuticals Inc | Viridian Therapeutics Inc | Genzyme Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | San Diego | Carlsbad | Pasadena | Waltham | Cambridge |
| State/Province | California | California | California | Massachusetts | Massachusetts |
| No. of Employees | 30 | 927 | 525 | 96 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Stelios Papadopoulos, Ph.D. | Chairman | Executive Board | 2013 | 74 |
| Joseph P. Hagan | President; Director; Chief Executive Officer | Executive Board | 2017 | 54 |
| Cris Calsada | Chief Financial Officer | Senior Management | 2019 | 53 |
| Christopher Aker | General Counsel; Senior Vice President | Senior Management | 2019 | 61 |
| Claire Padgett, Ph.D | Senior Vice President - Clinical Operations | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer